Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
SS-31: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after SS-31 therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to SS-31 overviewDuring Treatment (2 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| CK | ↓ decreases | Every 8 weeks |
| Lactate | ↓ decreases | Every 4 weeks |